QUOTED. 30 April 2021. Jeff Mäki
Finnish-based GlucoModicum is developing a painless, needle-free glucose-monitoring device that looks like a smartwatch to make managing pre-diabetes and undertreated type 2 diabetes more convenient. See what the CEO, Jeff Mäki, said about it here.
“Nobody wants to stick a needle into their body unless they have to.” – Jokke Mäki, CEO, GlucoModicum
- Find out more: Start-Up Spotlight: GlucoModicum Hopes To Market Disruptive Glucose Monitoring Technology
Click here for a free trial of Medtech Insight